Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EscharEx enzymatic debridement in hard-to-heal wounds
2015-001466-25Phase 2Completed
- Sponsor
- MediWound
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in stasis ulcer, diabetic foot ulcer (DFU), traumatic wound and 1 more comparing EscharEx with Vehicle control (2 arms). Primary endpoint: Complete debridement incidence. Started Apr 2015; status: completed.
02
Drugs
EscharEx
03
Conditions
stasis ulcerdiabetic foot ulcer (DFU)traumatic woundsurgical site infection (SSI)
Beyond the preview
Go deeper on 2015-001466-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001466-25.